This is a Validated Antibody Database (VAD) review about human CNOT7, based on 5 published articles (read how Labome selects the articles), using CNOT7 antibody in all methods. It is aimed to help Labome visitors find the most suited CNOT7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CNOT7 synonym: CAF-1; CAF1; Caf1a; hCAF-1
Abcam
domestic rabbit monoclonal (EPR18722) |
| Abcam CNOT7 antibody (Abcam, ab195587) was used in western blot on human samples at 1:1000 (fig 3a). elife (2019) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (18W) |
| Santa Cruz Biotechnology CNOT7 antibody (Santa cruz, Sc101009) was used in western blot on human samples (fig 3e). Nature (2017) ncbi |
mouse monoclonal (18W) |
| Santa Cruz Biotechnology CNOT7 antibody (Santa Cruz, 18W) was used in western blot on mouse samples (fig 2e). Genes Dev (2016) ncbi |
mouse monoclonal (18W) |
| In order to elucidate the function of m(6)A modifications, Santa Cruz Biotechnology CNOT7 antibody (Santa, sc-101009) was used in immunocytochemistry on human samples at 1:100. Nature (2014) ncbi |
GeneTex
domestic rabbit polyclonal |
| In order to develop reagents to study RNA binding proteins, GeneTex CNOT7 antibody (GeneTex, GTX118241) was used in immunocytochemistry on human samples at 2 ug/ml. Mol Cell (2016) ncbi |
Proteintech Group
domestic rabbit polyclonal |
| Proteintech Group CNOT7 antibody (Proteintech, 14102-1-AP) was used in western blot on human samples (fig 3c). Nature (2017) ncbi |
Articles Reviewed
- Yang C, Ramamoorthy S, Boller S, Rosenbaum M, Rodriguez Gil A, Mittler G, et al. Interaction of CCR4-NOT with EBF1 regulates gene-specific transcription and mRNA stability in B lymphopoiesis. Genes Dev. 2016;30:2310-2324 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments